Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO). Date on which the share buy-back programme was announced: 30 November 2022. The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General [...]

CSAM Health Group realises cost synergies to restore profitability levels

CSAM Health Group AS (CSAM), a leading provider of specialised software for healthcare, will implement a group-wide cost-saving program that will ensure reaching the target EBITDA margin of 30% for fully integrated business areas and products, as previously announced in the Q3 report published on 30 November 2022. The comprehensive program covers all business units, [...]

Announcement of launch of share buyback program

30 November 2022: CSAM Health Group AS (the «Company») has decided to proceed with the buyback of up to 666,666 of its own shares in accordance with the authorization granted to the board of directors by the Company’s general meeting held on 19 May 2022 as arranged for by the written bondholders’ resolution, announced on [...]

CSAM delivers growth in ARR and 5% EBITDA margin in Q3-22

Oslo, Norway, 30 November 2022: Today, CSAM Health Group AS (CSAM), a leading provider of specialised software for healthcare, published its results for the third quarter of 2022. CSAM reports an EBITDA margin of 5% for Q3-22 and an increase of ~5% in recurring revenue compared to Q3-21. CSAM’s long-term relations with healthcare providers and [...]

Invitation to presentation of CSAM Health Group’s Q3 results

CSAM Health Group AS (CSAM) will publish its results for the third quarter of 2022 on Wednesday, 30 November at 08:00 CET (UTC +1) on and A presentation of the results, including a discussion of recent events, will be given by CEO Sverre Flatby and CFO Einar Bonnevie at 08:30 CET (UTC +1) [...]

Notice from Written Resolution/Bondholder Meeting

Today a Written Resolution was resolved pursuant to the summons for a Written Resolution dated 11 October 2022. The Notice from the Written Resolution can be downloaded here. This will enable CSAM to move forward with the previously announced share buyback programme. For more information, please contact: Einar Bonnevie Chief Financial Officer +47 91 55 [...]

CSAM Health Group AS – Notice of written resolution of bondholders

ISIN: NO 001 0893738 - CSAM Health Group AS FRN senior secured NOK 500,000,000 bonds 2020/2024 Nordic Trustee has today issued a notice of written resolution to the holders of bonds in the above-mentioned bond issue for the purpose of seeking an amendment to the bond terms dated 24 September 2020, to allow for a [...]

CSAM Health Group AS: Minutes from Extraordinary General Meeting

An Extraordinary General Meeting of CSAM Health Group AS was held today, 3 October 2022, at the Company's headquarters in Oslo. In accordance with the Board of Directors’ proposal, the Extraordinary General Meeting resolved to elect PwC as the Company’s auditor with effect from 4 October 2022. Download the minutes from the meeting here For [...]

CSAM Health Group AS – Notice of Extraordinary General Meeting

The Board of Directors of CSAM Health Group AS hereby convenes an Extraordinary General Meeting at the Company's offices in Drammensveien 288, 0283 Oslo, on 3 October 2022 at 12:00 CEST (UTC +2). The purpose of the meeting is the appointment of a proposed new auditor for CSAM Health Group AS. The Board encourages all [...]

Presentation of CSAM Health Group’s results for the second quarter of 2022

Today, CSAM Health Group AS (CSAM) presented its financial results for the second quarter of 2022 during a shareholder webcast. CEO Sverre Flatby discussed highlights from the report and CFO Einar Bonnevie presented a detailed overview of the financial results for the quarter. The presentation is available for download and the full webcast can be [...]